Nasdaq OMX Group Inc. diskutieren
Nasdaq OMX Group Inc.
WKN: 813516 / Symbol: NDAQ / Name: Nasdaq OMX / Aktie / Investment Banking & Finanzdienstleistungen / Large Cap /
71,17 €
3,73 %
Nasdaq (NASDAQ:NDAQ) had its "overweight" rating reaffirmed by analysts at Morgan Stanley. They now have a $111.00 price target on the stock.
Ratings data for NDAQ provided by MarketBeat
Nasdaq (NASDAQ:NDAQ) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Ratings data for NDAQ provided by MarketBeat
Nasdaq (NASDAQ:NDAQ) had its price target raised by analysts at JPMorgan Chase & Co. from $111.00 to $113.00. They now have an "overweight" rating on the stock.
Ratings data for NDAQ provided by MarketBeat
Nasdaq (NASDAQ:NDAQ) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for NDAQ provided by MarketBeat
Nasdaq (NASDAQ:NDAQ) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada. They now have a $108.00 price target on the stock.
Ratings data for NDAQ provided by MarketBeat
Nasdaq (NASDAQ:NDAQ) was given a new $116.00 price target on by analysts at Morgan Stanley. They now have an "overweight" rating on the stock.
Ratings data for NDAQ provided by MarketBeat
Nasdaq (NASDAQ:NDAQ) had its price target raised by analysts at JPMorgan Chase & Co. from $100.00 to $101.00. They now have an "overweight" rating on the stock.
Ratings data for NDAQ provided by MarketBeat
Nasdaq (NDAQ) had its "outperform" rating reaffirmed by Raymond James Financial, Inc..
Ratings data for NDAQ provided by MarketBeat
Neueste Beiträge
Barrington_Research in Merit Medical Systems diskutieren